QualityStocksNewsBreaks Archives - Page 1351 of 1419

MondayFeb 26, 2018 12:24 pm

QualityStocksNewsBreaks – Consorteum Holdings, Inc. (CSRH) Mobile 359 Subsidiary Inks Deal with DevLex to Launch Predictive Analytics Platform

Software development and mobile solutions company Consorteum Holdings (OTC: CSRH) today announced that its wholly owned subsidiary, 359 Mobile Inc., has inked a new partnership deal with DevLex Ltd. The deal seeks to augment DevLex’s predictive analytics platform (“DV-PA”) with 359’s Universal Mobile Interface™ ("UMI"). 359’s flagship product, UMI, was recently integrated to facilitate a multitude of FinTech-based services. The alliance will expand the DV-PA platform to a range of vertical market solutions of 359 to new sectors like FinTech, sports wagering, commodities management, and other record-based, data management sectors. "DevLex's expertise in complex localized large scale predictive analytics is…

MondayFeb 26, 2018 11:55 am

QualityStocksNewsBreaks – IEG Holdings Corp. (IEGH) Signs Intellectsoft for Cryptocurrency Blockchain Development Services; Discloses Potential Philippines Cryptocurrency Remittance Strategy

IEG Holdings Corp. (OTCQB: IEGH) this morning announced that Investment Evolution Crypto LLC, its wholly owned subsidiary, has outsourced Intellectsoft LLC to offer blockchain development services including functional and business requirement analysis; technical and market research; and a development plan for the development of IEG Holdings' cryptocurrency. IEGH also revealed that its subsidiary is planning to penetrate the Filipino USD 28 billion Overseas Foreign Workers (“OFWs”) remittance market, by developing and launching a cryptocurrency targeting both the Australian and US based Philippines OFWs. Per the update, its subsidiary is in the initial stages of these plans, and it will investigate…

MondayFeb 26, 2018 11:17 am

QualityStocksNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Appoints Director of International Operations

Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) this morning announced its appointment of Dr. Maher Khaled to the position of director of international operations. Khaled bolsters the PreveCeutical team with more than a decade of experience in commercializing therapeutic and diagnostic technologies, most recently at UniQuest Pty Ltd. Moving forward, he will be involved in overseeing PreveCeutical’s development of therapeutic technologies, as well as managing the company’s ongoing operations in Australia, reviewing acquisition and licensing opportunities and leading commercialization efforts for its growing IP portfolio. “We are delighted to have Dr. Khaled as part of…

MondayFeb 26, 2018 10:29 am

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Enters Global Licensing Agreement with Neutrisci International Inc. (TSX-V: NU) (OTCQB: NRXCF)

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) this morning said it has entered an agreement with NeutriSci International Inc. (TSX-V: NU) (OTCQB: NRXCF) resulting in NeutriSci now having 100% ownership of Ambarii Trade Corporation. Lexaria has also granted to NeutriSci an Intellectual Property License and Supply Agreement for the manufacturing and sale of CBD based products. Per the License Agreement, NeutriSci will remain focused on the development and sales of its existing and pipeline products that include Lexaria's technology for enhancing palatability and bioavailability of beneficial non-psychoactive cannabinoids. Lexaria will receive continuing royalty revenues from the sales generated by these products.…

MondayFeb 26, 2018 10:12 am

QualityStocksNewsBreaks – PotNetwork Holding, Inc. (POTN) Subsidiary Records More than $270,000 in Sales at CHAMPS Trade Show

PotNetwork Holding, Inc. (OTC: POTN), through wholly-owned subsidiary Diamond CBD, Inc., this morning announced that it recorded over $270,000 in sales at the 37th CHAMPS Trade Show, which took place at the Las Vegas Convention Center from February 19-21, 2018. Diamond CBD continued to build on its highly successful history of sales at such events at the CHAMPS winter show, its first major trade show of 2018. Per the update, the company’s performance at the show surpassed past records of trade show sales for its CBD product line. “Without a mistake, Diamond CBD is off to a great start in…

FridayFeb 23, 2018 12:08 pm

QualityStocksNewsBreaks – SinglePoint, Inc. (SING) CEO Discusses Recent LOI, Acquisition Strategy in Interview on MoneyTV

Specialized holding company SinglePoint, Inc. (OTCQB: SING) was a featured company on this week’s episode of MoneyTV with Donald Baillargeon. MoneyTV is an internationally syndicated television program discussing “money and what makes it happen.” In this week’s episode, SinglePoint CEO Greg Lambrecht discussed the company’s recently announced Letter of Intent (“LOI”) with ORHub, Inc. (OTC: ORHB) to develop a blockchain services platform for health care applications. Per the agreement, ORhub will engage SinglePoint for up to $750,000 in initial development costs. Lambrecht also updated viewers on the company’s plans for 2018, including its aggressive acquisition strategy moving forward. Per the…

FridayFeb 23, 2018 11:29 am

QualityStocksNewsBreaks – Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) Signs Agreement to Acquire Sechelt Organic Marijuana Corp.

Veritas Pharma (CSE: VRT) (OTC: VRTHF) (FRT: 2VP), a pharmaceutical and IP development firm, this morning announced that it has signed an agreement with 906474 ALBERTA LTD (“the vender”), to purchase 100% ownership of Sechelt Organic Marijuana Corp (“SOM”). Under the agreement, Veritas Pharma will purchase all outstanding shares of SOM at a price of $800,000, subject to provisions of the closing agreement. The agreement requires the vender and SOM to give Veritas Pharma unlimited access to the operations, assets, properties, and records of SOM to help it familiarize with the operations, assets, records, properties and other matters on continuous…

FridayFeb 23, 2018 11:02 am

QualityStocksNewsBreaks – MGX Minerals Inc. (CSE: XMG) (FKT: 1MG) (OTCQB: MGXMF) Proceeds with Highbury Energy Partnership; Posts Initial Vanadium Nickel Cobalt Assay Results

Diversified resource and technology company MGX Minerals Inc. (CSE: XMG) (FKT: 1MG) (OTCQB: MGXMF) this morning announced that the company has decided to proceed with its partnership with Highbury Energy, Inc. The two companies intend to develop a detailed thermochemical gasification process to extract metals such as nickel, vanadium, cobalt, and hydrogen from petroleum coke ("Petcoke"). Additionally, the company received initial vanadium nickel cobalt assay results. The samples were obtained from Alberta oil sands and refinery sales stockpile, which showed Vanadium 421 parts per million (“ppm), Cobalt 4.8 ppm and Nickel 76.8 ppm; and Vanadium 458 ppm, Cobalt 1.3 ppm…

ThursdayFeb 22, 2018 4:15 pm

QualityStocksNewsBreaks – Skinvisible, Inc. (SKVI) Preparing to Enter the Post-Surgical Pain Management Market through Proposed Merger

Research and development company Skinvisible (OTCQB: SKVI) previously announced the signing of a Letter of Intent for a proposed merger with Quoin Pharmaceuticals Limited, which would successfully mark the company’s entrance into the post-surgical pain management market. The partnership has the potential to address significant unmet medical needs on the pain management market. An article discussing the company’s endeavor reads: “Currently, the pain management market in the U.S. is fueled by a number of sectors. The most prominent ones include post-operative pain relief, arthritis pain, cancer pain, migraine and neuropathic pain. As larger Western populations age and become susceptible to…

ThursdayFeb 22, 2018 3:55 pm

QualityStocksNewsBreaks – Teewinot Life Sciences Produces Cannabinoids through Patent-protected CANNSYNTHESIS Technology

Cannabinoid-based pharmaceuticals company Teewinot Life Sciencess employs its patent-protected CANNSYNTHESIS® technology to biosynthesize cannabinoids for the large-scale manufacture of pharmaceutically pure cannabinoids. An article discussing the company’s technology reads: “Apart from THC and CBD, many of the 111 or so cannabinoids found in the cannabis plant are produced in minute quantities. Production by extraction is thus prohibitively costly, meaning that most cannabinoids have not been available for research and therapeutic applications. The CANNSYNTHESIS® platform has changed that paradigm, however, since it allows for the efficient production of cannabinoids in kilogram quantities. Teewinot’s CANNSYNTHESIS® has taken the production of cannabinoids from…

Site Search

Company Search

Category: QualityStocksNewsBreaks